153 related articles for article (PubMed ID: 26574486)
1. Endovascular Therapy for Femoropopliteal Artery Disease and Association of Risk Factors With Primary Patency: The Implication of Critical Limb Ischemia and TASC II C/D Disease.
Nishibe T; Yamamoto K; Seike Y; Ogino H; Nishibe M; Koizumi J; Dardik A
Vasc Endovascular Surg; 2015 Nov; 49(8):236-41. PubMed ID: 26574486
[TBL] [Abstract][Full Text] [Related]
2. Endovascular treatment of TransAtlantic Inter-Society Consensus II D femoropopliteal lesions in patients with critical limb ischemia.
Biagioni RB; Brandão GD; Biagioni LC; Nasser F; Burihan MC; Ingrund JC
J Vasc Surg; 2019 May; 69(5):1510-1518. PubMed ID: 30611581
[TBL] [Abstract][Full Text] [Related]
3. Contemporary outcomes after superficial femoral artery angioplasty and stenting: the influence of TASC classification and runoff score.
Ihnat DM; Duong ST; Taylor ZC; Leon LR; Mills JL; Goshima KR; Echeverri JA; Arslan B
J Vasc Surg; 2008 May; 47(5):967-74. PubMed ID: 18372147
[TBL] [Abstract][Full Text] [Related]
4. Results of primary stent therapy for femoropopliteal peripheral arterial disease at 7 years.
Stavroulakis K; Torsello G; Manal A; Schwindt A; Hericks C; Stachmann A; Schönefeld E; Bisdas T
J Vasc Surg; 2016 Dec; 64(6):1696-1702. PubMed ID: 27575816
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.
Veraldi GF; Mezzetto L; Macrì M; Criscenti P; Corvasce A; Poli R
Ann Vasc Surg; 2018 Feb; 47():179-187. PubMed ID: 28943491
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of femoropopliteal stenting. Results of a prospective study.
Schönefeld E; Torsello G; Osada N; Herten M; Bisdas T; Donas KP
J Cardiovasc Surg (Torino); 2013 Oct; 54(5):617-23. PubMed ID: 24002391
[TBL] [Abstract][Full Text] [Related]
7. Impact of femoropopliteal endovascular interventions on subsequent open bypass.
Gifford SM; Fleming MD; Mendes BC; Stauffer KC; De Martino RR; Oderich GS; Gloviczki P; Bower TC
J Vasc Surg; 2016 Sep; 64(3):623-8. PubMed ID: 27288105
[TBL] [Abstract][Full Text] [Related]
8. Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease.
Tran K; Ullery BW; Kret MR; Lee JT
Ann Vasc Surg; 2017 Jan; 38():90-98. PubMed ID: 27554688
[TBL] [Abstract][Full Text] [Related]
9. Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent.
Nguyen BN; Conrad MF; Guest JM; Hackney L; Patel VI; Kwolek CJ; Cambria RP
J Vasc Surg; 2011 Oct; 54(4):1051-1057.e1. PubMed ID: 21636240
[TBL] [Abstract][Full Text] [Related]
10. Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study.
Reijnen MMPJ; van Wijck I; Zeller T; Micari A; Veroux P; Keirse K; Lee SW; Li P; Voulgaraki D; Holewijn S
J Endovasc Ther; 2019 Jun; 26(3):305-315. PubMed ID: 30931726
[TBL] [Abstract][Full Text] [Related]
11. The success of endovascular therapy for all TransAtlantic Society Consensus graded femoropopliteal lesions.
Han DK; Shah TR; Ellozy SH; Vouyouka AG; Marin ML; Faries PL
Ann Vasc Surg; 2011 Jan; 25(1):15-24. PubMed ID: 20932714
[TBL] [Abstract][Full Text] [Related]
12. Endovascular treatment of lesions in the below-knee popliteal artery.
Siracuse JJ; Gill HL; Cassidy SP; Messina MD; Catz D; Egorova N; Parrack I; McKinsey JF
J Vasc Surg; 2014 Aug; 60(2):356-61. PubMed ID: 24650745
[TBL] [Abstract][Full Text] [Related]
13. Results of second-time angioplasty and stenting for femoropopliteal occlusive disease and factors affecting outcomes.
Robinson WP; Nguyen LL; Bafford R; Belkin M
J Vasc Surg; 2011 Mar; 53(3):651-7. PubMed ID: 21129908
[TBL] [Abstract][Full Text] [Related]
14. The association of statin therapy with the primary patency of femoral and popliteal artery stents.
de Grijs D; Teixeira P; Katz S
J Vasc Surg; 2018 May; 67(5):1472-1479. PubMed ID: 29224939
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of intravascular ultrasound in femoropopliteal stenting for peripheral artery disease with TASC II class A to C lesions.
Iida O; Takahara M; Soga Y; Suzuki K; Hirano K; Kawasaki D; Shintani Y; Suematsu N; Yamaoka T; Nanto S; Uematsu M
J Endovasc Ther; 2014 Aug; 21(4):485-92. PubMed ID: 25101575
[TBL] [Abstract][Full Text] [Related]
16. Primary stenting of the superficial femoral and popliteal artery.
Dearing DD; Patel KR; Compoginis JM; Kamel MA; Weaver FA; Katz SG
J Vasc Surg; 2009 Sep; 50(3):542-7. PubMed ID: 19540706
[TBL] [Abstract][Full Text] [Related]
17. Atherectomy offers no benefits over balloon angioplasty in tibial interventions for critical limb ischemia.
Todd KE; Ahanchi SS; Maurer CA; Kim JH; Chipman CR; Panneton JM
J Vasc Surg; 2013 Oct; 58(4):941-8. PubMed ID: 23755978
[TBL] [Abstract][Full Text] [Related]
18. Primary stenting for TASC C and D femoropopliteal lesions: one-year results from a multicentric trial on 203 patients.
Brouillet J; Deloose K; Goueffic Y; Poirier M; Midy D; Caradu C; Ducasse E
J Cardiovasc Surg (Torino); 2018 Jun; 59(3):392-404. PubMed ID: 27272981
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of balloon angioplasty alone versus nitinol stent implantation in patients with small femoropopliteal artery disease: Observations from the Retrospective Multicenter Analysis for Femoropopliteal Stenting (REAL-FP).
Kamioka N; Soga Y; Kuramitsu S; Iida O; Hirano K; Suzuki K; Kawasaki D; Yamaoka T; Suematsu N; Shintani Y; Miyashita Y; Takahashi H; Tsuchiya T; Shinozaki N; Okazaki S; Ando K
Catheter Cardiovasc Interv; 2017 Nov; 90(5):790-797. PubMed ID: 28722294
[TBL] [Abstract][Full Text] [Related]
20. Endovascular management of patients with critical limb ischemia.
Conrad MF; Crawford RS; Hackney LA; Paruchuri V; Abularrage CJ; Patel VI; Lamuraglia GM; Cambria RP
J Vasc Surg; 2011 Apr; 53(4):1020-5. PubMed ID: 21211929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]